Audible Premium Plus. $0.99/mo for the first 3 months + $20 Audible credits. 12 days only. Get this deal. Cancel anytime.

Residual tumor volume and survival after CCNU/TMZ in GBM
Nov 24 2024
Length: 13 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Residual tumor volume and survival after CCNU/TMZ in GBM

Listen for free

View show details

Summary
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.

Show more Show less

Show more Show less

What listeners say about Residual tumor volume and survival after CCNU/TMZ in GBM

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon